Dr. Rosenfarb recently teamed with researchers at Johns Hopkins University on the first ever clinical study to determine the efficacy of treating Retinitis Pigmentosa with acupuncture and other TCM therapies. Dr. Rosenfarb drew on his extensive training and clinical experience to develop the treatment protocol and trained staff at Johns Hopkins University to administer it to study participants.
Based on the success of that initial study, the NIH is funding a second, expanded clinical study in 2014 that will once again utilize Dr. Rosenfarb’s treatment protocol. The first peer-reviewed study was recently published in Clinical and Experimental Optometry.
To view the article, click here .